Stereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate Cancer

Stereotactic Body Radiation Therapy for Unresectable Locally Recurrent Rectal Cancer

NCT07297004 ·Status: RECRUITING ·Phase: PHASE2

A Study of Radiotherapy Combined With Raltitrexed and Irinotecan in Metastatic or Locally Recurrent Colorectal Cancer

NCT04499586 ·Status: UNKNOWN ·Phase: PHASE2

Phase II Study of Preoperative IMRT Combined With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer

NCT01871363 ·Status: UNKNOWN ·Phase: PHASE2

Trial of Using SIB-IMRT in Preoperative Radiotherapy for Locally Advanced Rectum Cancer

NCT02195141 ·Status: UNKNOWN ·Phase: PHASE2

MRI Simulation-guided Boost in Short-course Preoperative Radiotherapy for Unresectable Rectal Cancer

NCT03714490 ·Status: RECRUITING ·Phase: PHASE2

Simultaneous Boost in Neoadjuvant Radiotherapy for Rectal Cancer

NCT07200141 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.

NCT06349044 ·Status: RECRUITING ·Phase: NA

UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer

NCT05148767 ·Status: RECRUITING ·Phase: PHASE4

High Dose Radiotherapy for the Treatment of Rectal Cancer

NCT03541304 ·Status: COMPLETED

Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC

NCT06992232 ·Status: RECRUITING ·Phase: PHASE2

Involve-site Radiotherapy Combined With Chemotherapy and Immunotherapy as Neoadjuvant Treatment for Locally Advanced Rectal Cancer

NCT07161115 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

the Re-irradiation of Recurrent Cervical Cancer by IMRT

NCT03170570 ·Status: UNKNOWN ·Phase: NA

IMRT Versus 3DCRT for Locally Advanced Rectal Cancer, Prospective Phase II Study.

NCT06160570 ·Status: COMPLETED ·Phase: NA

SCRT + mFOLFOX6 + PD-1 Antibody + Targeted Therapy for HIgh-Risk pMMR/MSS Rectal Cancer

NCT06908031 ·Status: RECRUITING ·Phase: PHASE2

SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer

NCT07297030 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

the Efficacy of MR-guided Online Adaptive Radiotherapy for Locally Advanced Rectal Cancer

NCT07080411 ·Status: NOT_YET_RECRUITING ·Phase: NA

SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）

NCT06767007 ·Status: RECRUITING ·Phase: PHASE2

Stereotactic Body Radiotherapy for Oligometastases From Colorectal Cancer

NCT02909114 ·Status: UNKNOWN ·Phase: PHASE2

Microwave Ablation Versus Stereotactic Body Radiotherapy for Colorectal Liver Metastases in Oligometastatic Disease: a Prospective, Randomised, Phase 2 Trial

NCT03654131 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Pre-operative 3-DCRT vs IMRT for Locally Advanced Rectal Cancer

NCT02151019 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Radiotherapy Combined With Tislelizumab and Irinotecan in MSS/pMMR Recurrence and Metastatic Colorectal Cancer

NCT05160727 ·Status: UNKNOWN ·Phase: PHASE2

Focal Radiotherapy for Previously Treated Prostate Cancer Patients

NCT03073278 ·Status: RECRUITING ·Phase: NA

Adjuvant IMRT With Concommitant Raltitrexed Chemotherapy for Locally Advanced Gastric Cancer After D0/D1 Radical Resection

NCT03392103 ·Status: UNKNOWN ·Phase: PHASE2

Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer

NCT07154316 ·Status: RECRUITING ·Phase: PHASE2

Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the Treatment of Unresectable Advanced GIST

NCT06507683 ·Status: RECRUITING ·Phase: NA